| Study title |
Madrigal-11: A Phase 3, Multinational, Double-Blind, Randomized,Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With NASH and Fibrosis to Resolve NASH and reduce Progression to Cirrhosis |
| Disease or condition |
NAFLD/NASH with Fibrosis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
MGL-3196 (Resmetirom) or Placebo |
| Phase |
3 |
| Study site |
Duke University |
| Study location |
Durham, NC |
| Principal investigator |
Anna Mae Diehl, MD |
| Study coordinator |
Magdi Elgasim, Phone: 919-684-9019 Email: magdi.elgasim@duke.edu |
| Phone contact |
(919) 613-8802 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT03900429 |
